Patients saw “significant” reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics sending shares of the biopharmaceutical company soaring in premarket trading Tuesday.
February 27, 2024 - 15:42
By Pharos Investment Advisors Comments are Off
Patients saw “significant” reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics sending shares of the biopharmaceutical company soaring in premarket trading Tuesday.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved